Fig. 1From: Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomasStudy flow chart showing included and excluded patients. CCRT = concurrent chemoradiotherapy; IDH = isocitrate dehydrogenaseBack to article page